Photonics commercializes tissue surgery laser

Singapore: Photonics, which recently received investments from Maxwell Biotech Venture Fund and RVC Seed Fund, has made ...

February 13, 2013 | Wednesday | News
Chugai, Gilead get Japanese approval for additional indication of antiviral drug Copegus

Chugai Pharmaceutical Co. Ltd. has obtained approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for...

March 30, 2015 | Monday | News
Japan approves BioSpecifics' Dupuytren's Contracture treatment

Tokyo: BioSpecifics Technologies Corp., a US-based biopharmaceutical company developing collagenase-based products, has ...

July 21, 2015 | Tuesday | News
Astellas-Cyclenium ink drug discovery collaboration

Singapore: Quebec's Cyclenium Pharma has signed a drug discovery collaboration agreement with Astellas Pharma in Tokyo....

May 13, 2015 | Wednesday | News
Takeda acquires US biologics manufacturing facility

Singapore: Takeda Pharmaceutical announced the acquisition of a biologics manufacturing facility located in Brooklyn Par...

January 7, 2016 | Thursday | News
INTERPHEX JAPAN / in-PHARMA JAPAN 2015 to be held at Tokyo Big Sight, Japan

Tokyo: The 28th INTERPHEX JAPAN and 9th in-PHARMA JAPAN will be held at Tokyo Big Sight from July 1st to 3rd, 2015 at th...

June 19, 2015 | Friday | News
Japan pharma market worth $80 billion by 2020: Global Data

Singapore: According to research and consulting firm Global Data, the Japanese pharmaceutical market is poised to grow a...

March 1, 2015 | Sunday | News
How will Asia tackle total drug resistant TB?

The latest concern to have plagued the field of tuberculosis (TB) is the emergence of total drug resistant TB (TDR-TB). ...

March 23, 2012 | Friday | News
BioSpectrum announces the hits and misses of 2013

Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...

January 2, 2014 | Thursday | Analysis
“Many foreign CROs are often hesitant to make big investments in Japan”

Founded in 1983, BBK Worldwide is a marketing consultancy firm specializing in patient recruitment for clinical R&D ...

August 14, 2015 | Friday | Opinion
Takeda collaborates with Keio University

Singapore: Japanese pharma major, Takeda Pharmaceutical Company has signed an agreement to undertake collaborative resea...

April 23, 2015 | Thursday | News
FDA approves additional indication of Eisai's anticancer agent Lenvima

Japan's Eisai Co Ltd has announced that its US subsidiary Eisai Inc. has received approval from the US Food and Drug Adm...

May 17, 2016 | Tuesday | News
PharmaMar seeks Japan PMDA approval for tissue sarcoma drug

The Japanese Pharmaceutical Affairs and Food Sanitation Council (PAFSC) has recommended an approval for Madrid-based Pha...

September 2, 2015 | Wednesday | News
Treatment for rare metabolic disorder approved in Japan

NASDAQ-listed Alexion Pharmaceuticals Inc. has announced that Japan's Ministry of Health, Labour and Welfare (MHLW) appr...

July 7, 2015 | Tuesday | News
ILS strengthens Bachem's peptide business in Japan

Tokyo: Switzerland's Bachem and Initiative for Life Sciences (ILS) have decided to strengthen their co-marketing efforts...

September 9, 2015 | Wednesday | News
Japan to provide medical assistance to Kyrgyzstan

Singapore: In a bid to improve medical services and healthcare scenario in Kyrgyzstan, Japan has inked a pact with five ...

March 9, 2015 | Monday | News
Astellas sells Kiyosu Plant business to MicroBiopharm Japan

Tokyo: Pharma giant Astellas Pharma Inc. has announced that the company and MicroBiopharm Japan Co. Ltd. (MBJ) have conc...

November 2, 2015 | Monday | News
“Engineered 3D human tissue will bring efficiencies in drug screening and drug safety testing”

First, could you give the readers a short bio of your company?Cyfuse is a regenerative medicine startup founded in 2010 ...

June 30, 2015 | Tuesday | Opinion

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls